The VALIDATE Network aims to accelerate vaccine research and development for complex intracellular pathogens that cause diseases significant to low and middle-income countries (LMIC), with an initial focus on Mycobacterium tuberculosis, Leishmania spp, Burkholderia pseudomallei and Mycobacterium leprae. VALIDATE also aims to facilitate Continuing Professional Development (CPD) and career progression amongst its members.
VALIDATE is proud to partner with the Collaboration for Tuberculosis Vaccine Discovery (CTVD) for our 2021-2023 calls. CTVD is an international network of scientists and experts dedicated to fostering innovation, cooperation, and collaboration in the up-stream TB vaccine discovery, translational research and development space. CTVD serves as the Bill & Melinda Gates Foundation’s major mechanism for enhancing collaboration in the field.
To support these aims, Early Career Researcher training grants are available of up to £3500 via competitive application to the VALIDATE Network Management Board (NMB) to help researchers take advantage of training opportunities that will contribute to their CPD. This can include (but is not limited to): attendance at courses or workshops, laboratory exchanges, and work shadowing. Attendance at an international conference to present a talk or poster is also eligible for LMIC members only (general travel to attend conferences is not supported in this fund; travel to the VALIDATE Network Annual Meeting is funded elsewhere). For laboratory exchanges, we encourage you to maximise the outputs of your visit to that laboratory, for example by visiting other relevant VALIDATE researchers in that country (to increase your network of contacts and discuss future collaboration opportunities), or by giving a talk to your host laboratory about your research during your visit.
Training opportunities can be within, or external to, the VALIDATE Network; we advertise those we know of here but you can apply for other opportunities you hear of as well. The VALIDATE Members' Directory may also give you ideas for potential laboratory exchanges, tech transfer, or industry visits.
- The proposed training opportunity must fall within the VALIDATE remit. Please note that for the VALIDATE-CTVD joint calls, only research focused on tuberculosis vaccine development is eligible. Any aspect of research that will accelerate development of an efficacious TB vaccine is eligible, including biological, physical and social sciences, and humanities.
- Applicants must be an Associate member of VALIDATE, and/or a post-doctoral scientist working on research directly related to TB vaccine development nominated by a CTVD member. We particularly welcome applications from researchers based in LMICs.
The grants are awarded via competitive application to the Network Management Board. You can read about previous awardees here.
Please submit your application form (below) and associated documents by email as a single pdf to the Network Management Team (firstname.lastname@example.org) by 4pm (UK time) on the call closing date. Please ensure you read our application guidance document (below) before you begin writing your application. Please also contact us with any queries.
List of LMICs (all countries listed on this document count as 'LMIC')
Round 15 (TB only) - opens Dec 2022; closes Feb 2023
Round 14 (TB only) - opens Aug 2022; closes Oct 2022
Round 13 (TB only) - opens 14 Apr 2022; closes 20 Jun 2022
Round 12 (TB only) - 7 March 2022 (closed and awarded)
Previous (closed) calls
Round 11 - 18 February 2021 (closed and awarded)
Round 10 - 13 October 2020 (closed and awarded)
Round 9 - 17 June 2020 (closed and awarded)
Round 8 - 24 February 2020 (closed and awarded)
Round 7 - 22 October 2019 (closed and awarded)
Round 6 - 24 June 2019 (closed and awarded)
Round 5 - 12 February 2019 (closed and awarded)
Round 4 - 29 October 2018 (closed and awarded)
Round 3 - 14 June 2018 (closed and awarded)
Round 2 - 14 February 2018 (closed and awarded)
Round 1 - 31 October 2017 (closed and awarded)